Purification of Ribonuclease H As a Factor Required for Initiation of in Vitro Colel DNA Replication

Total Page:16

File Type:pdf, Size:1020Kb

Purification of Ribonuclease H As a Factor Required for Initiation of in Vitro Colel DNA Replication Volume 10 Number 19 1982 Nucleic Acids Research Purification of ribonuclease H as a factor required for initiation of in vitro ColEl DNA replication Tateo Itoh and Jun-ichi Tomizawa Laboratory of Molecular Biology, National Institute of Arthritis, Diabetes, and Digestive and Kid- ney Diseases, National Institutes of Health, Bethesda, MD 20205, USA Received 2 July 1982; Revised and Accepted 1 September 1982 ABSTRACT Escherichia coli ribonuclease H was purified to near-homogeneity and identified as the only additional factor required for initiation of in vitro ColEl DNA replication from the unique origin by RNA polymerase and DNA poly- merase I. Both ribonuclease H activity and stimulating activity for ColEl DNA synthesis comigrate with the single protein band in gel electrophoresis. These two activities coincide throughout the process of purification. Some DNA synthesis takes place on covalently closed-circular DNA molecules other than ColEl DNA with the three purified enzymes. This DNA synthesis is suppressed by an Esherichia coli single-strand DNA binding protein and/or a high concentration of ribonuclease H. Negative superhelicity of template DNA is required for efficient primer formation. No evidence that supports involvement of ribonuclease III in iniilation of ColEl DNA replication or its regulation was found. INTRODUCTION Colicin El plasmid (ColEl) can be replicated in vitro by a soluble enzyme systeml. This replication starts at a unique site on the genome2 and does not require plasmid-coded proteins3. We have previously shown that Escherichia coli ribonuclease H (RNase H) is required for initiation of in vitro ColEl DNA replication by RNA polymerase and DNA polymerase I4. In this paper we describe, in detail, the procedure of purification of RNase H as a factor re- quired for initiation of in vitro ColEl DNA replication and some properties of DNA synthesis mediated by RNA polymerase, RNase H and DNA polymerase I. The mechanisms of primer formation by RNA polymerase and RNase H5 and of its regulation by a plasmid-specified small RNA (RNA I) have been described6,7. MATERIALS AND METHODS Bacteri and plsmids.E. coli K12 NT5258 grown in H broth to the end of the logarithmic phase was used as a source of RNase H. E. coli strains AB301-1059, N207710 and BL10711 possess the same rnclO5 mutation in differ- ent genetic backgrounds. Plasmids used were ColEll and its small derivatives pNT112 and pNT75. C IRL Press Umited, Oxford, England. 5949 0305-1048/82/1019-5949$ 2.00/0 Nucleic Acids Research Nucleic Acids. Supercoiled molecules of plasmid DNA were purified after extensive treatment with RNase A as described4. Relaxed closed circular mole- cules of pNT7 DNA were prepared by treating supercoiled molecules with the superhelical DNA relaxing enzyme13 from HeLa cell nuclei which was a gift of N. Nossal. Xdvl DNA and *X174 RFI DNA were purchased from Boehringer Mannheim QmbH and Bethesda Research Laboratory, respectively. Phage fl RFI DNA and SV40 Form I DNA were gifts of G. Selzer and N. Salzman, respectively. Enzymes. E. coli single-stranded DNA binding protein (SSB) and a sample of RNase H were gifts of S. Wickner and J. Hurwitz, respectively. The holo- enzyme of RNA polymerase and DNA polymerase I (provided by A. Kornberg) were as described5. RNase III was prepared as describedl4. Buffers. Buffer I: 50 mM Tris-HCl pH 7.5/0.1 M NaCl/10% sucrose. Buffer II: 50 mM Tris-HCl pH 7.5/0.1 M NaCl/l mM dithiothreitol (DTT)/l mM EDTA/20% glycerol. Buffer III: 20 mM Tris-HCl pH 8.9/3 mM DTT/l mM EDTA/10% glycerol. Buffer IV: 20 mM Tris-HCl pH 7.5/3 mM DTT/l mM EDTA/10% glycerol. Buffer V: 50 mM Tris-HCl pH 7.5/0.3 M NaCl/l mM DTT/1 mM EDTA/20% glycerol. Buffer VI: 50 mM Tris-HCl pH 7.5/0.1 M NaCl/l mM DTT/l mM EDTA/50% glycerol. Other Materials. DNA-agarose prepared as described15 was a gift of R. E. Bird. All other materials were obtained from commercial sources. RNase H Assay. The standard reaction mixture (50 il) for RNase H assay'6 contained 40 mM Tris-HCl pH 7.8/4 mM MgCl2/1 mM DTT/22 PM [3H]poly A (15,000 cpm/nmol AMP)/25 jiM poly dT/30 pg/ml of bovine serum albumin/4% glycerol and an appropriate amount of RNase H. RNase III Assay. RNase III activity was measured as described using poly(r[14C]A-U) (6000 cpm/nmol) as substrate 17. Transcription and DNA Synthesis. Conditions for transcription of plas- mid DNA have been described5-7. The standard reaction mixture (30 jil) for DNA synthesis4 contained 23 mM potassium phosphate buffer pH 7.4/7 mM Tris- HCl pH 7.8/8 mM MgC12/60 mM KC1/2 mM DTT/10% glycerol/2 mM spermidine/400 jiM ATP/200 PM each of other NTPs/25 jiM dNTPs including [a(-32P]dTT (500 to 2000 cpm/pmol)/100 jg/ml bovine serum albumin/5 units/ml RNA polymerase/25 units/ml DNA polymerase I/1.5 units/ml RNase H, or an appropriate amount of an enzyme fraction/10 jg/ml of DNA, usually ColEl DNA. Supercoiled molecules were used. Assays of Enzymatic Impurities. DNase: To assay for endonuclease, 0.7 jig of covalently closed circular ColEl DNA was incubated with 0.5 unit of RNase H in the RNase H assay mixture for 60 min at 30°C and then analyzed by 0.7% agarose gel electrophoresis. For assay of exonuclease, 0.01 pg [3H]thymidine labeled E. coli DNA (6 x 106 cpm/jg),either native or denatured, was incubated with 10 units of RNase H in the RNase H assay mixture for 60 5950 Nucleic Acids Research min at 37C and the formation of acid-soluble radioactivity was measured. RNase: Phage Xb2 transcripts that were used for assay of RNases were pre- pared by incubating Xb2 DNA (45 ig/ml) with RNA polymerase (15 units/ml) in a reaction mixture containing 20 mM Tris-HCl pH 7.9/5 mM MgC12/100 mM KC1/0.1 mM DTT/0.1 mM EDTA/150 pM NTPs including [a-32P]ATP (1,200 cpm/pmol) for 3 min at 37'C. RNA was purified by phenol treatment and concentrated by alcohol precipitation. [32P]Xb2 transcripts (0.02 pg: 2 x 104 cpm) were incubated with 5 units of RNase H in the RNase H assay mixture for 60 mmn at 370C. The forma- tion of acid-soluble radioactivity was used as a test for exonuclease and large amounts of endonuclease. The products were also analyzed by polyacrylamide/ urea gel electrophoresis to provide a more sensitive assay for any endonucle- ases including RNase III5. RNase III will give rise to disappearance of long XPL promoted transcripts and appearance of defined cleavage products 5 Other Methods. NaDodSO4/polyacrylamide (15%) gel electrophoresis of proteins was as describedl8. Protein was determined as describedl9,20 using bovine serum albumin as the standard. RESULTS Purification of RNase H. For purification of RNase H to near-homogeneity, it was necessary to modify the published procedure21. We found that the pre- vious method invariably yielded products that contained RNase III activity de- tectable by specific cleavage of XPL-promoted transcripts, and several other contaminating proteins. The rationale of the modification is as follows. When the previous method of DEAE cellulose chromatography at pH 7.5 was applied, RNase H activity, different from the "RNase H" activity of DNA polymerase I and exonuclease III was found both in the flow-through fraction and in the fraction that eluted at around 0.05 M NaCl as describedl6. The ratio of activities in these fractions varied from experiment to experiment. We inferred that this was due to a very slight affinity of RNase H for DEAE cellulose at pH 7.5. We therefore performed the chromatography at two differ- ent pHs. With Buffer III (pH 8.9), all RNase H activity was bound to DEAE- cellulose. With Buffer IV (pH 7.5), the enzyme eluted after unadsorbed material without application of a salt gradient. Successive use of these two conditions of DEAE cellulose chromatography removed RNase III and some contaminating proteins. A protein(s) that was eliminated by these procedures migrated at the same position as RNase H in gel electrophoresis. This contaminating protein was not retained at all by DEAE cellulose at pH 7.5. If not separated at this step, it was difficult to remove completely by the succeeding procedure. Some details of the method of purification are described 5951 Nucleic Acids Research below and in Table 1. All the operations were performed at around 4°C and centrifugation was at 20,000 g for 90 min. Chromatographic columns were always equilibrated with the starting buffer and the samples applied were dialyzed against the same buffer before loading. Cells of E. coli NT525 (206 g) in 600 ml of Buffer I were disrupted by passage through a Manton-Gaulin homogenizer (13,000 psi) and the debris were removed by centrifugation. To the supernatant (Fraction I, 720 ml), 226 g of ammonium sulfate was added and the precipitate was dissolved in 90 ml of Buff- er II. The solution (Fraction II, 135 ml) was applied onto a Bio-Gel A-5m column (5 x 80 cm) which was then washed with 2 1 of the buffer. RNase H activity eluted after about one column volume. Fractions (236 ml) containing RNase H activity, except those eluted earlier and contained DNA polymerase I activity, were pooled and 62 g of ammonium sulfate was added.
Recommended publications
  • Endogenous Reverse Transcriptase and Rnase H-Mediated Antiviral Mechanism in Embryonic Stem Cells
    www.nature.com/cr www.cell-research.com ARTICLE Endogenous reverse transcriptase and RNase H-mediated antiviral mechanism in embryonic stem cells Junyu Wu1, Chunyan Wu1, Fan Xing1, Liu Cao1, Weijie Zeng1, Liping Guo1, Ping Li1, Yongheng Zhong1, Hualian Jiang1, Manhui Luo1, Guang Shi2, Lang Bu1, Yanxi Ji1, Panpan Hou1, Hong Peng1, Junjiu Huang2, Chunmei Li1 and Deyin Guo 1 Nucleic acid-based systems play important roles in antiviral defense, including CRISPR/Cas that adopts RNA-guided DNA cleavage to prevent DNA phage infection and RNA interference (RNAi) that employs RNA-guided RNA cleavage to defend against RNA virus infection. Here, we report a novel type of nucleic acid-based antiviral system that exists in mouse embryonic stem cells (mESCs), which suppresses RNA virus infection by DNA-mediated RNA cleavage. We found that the viral RNA of encephalomyocarditis virus can be reverse transcribed into complementary DNA (vcDNA) by the reverse transcriptase (RTase) encoded by endogenous retrovirus-like elements in mESCs. The vcDNA is negative-sense single-stranded and forms DNA/RNA hybrid with viral RNA. The viral RNA in the heteroduplex is subsequently destroyed by cellular RNase H1, leading to robust suppression of viral growth. Furthermore, either inhibition of the RTase activity or depletion of endogenous RNase H1 results in the promotion of virus proliferation. Altogether, our results provide intriguing insights into the antiviral mechanism of mESCs and the antiviral function of endogenized retroviruses and cellular RNase H. Such a natural nucleic acid-based antiviral mechanism in mESCs is referred to as ERASE (endogenous RTase/RNase H-mediated antiviral system), which is an addition to the previously known nucleic acid-based antiviral mechanisms including CRISPR/Cas in bacteria and RNAi in plants and invertebrates.
    [Show full text]
  • Restriction Endonucleases
    Molecular Biology Problem Solver: A Laboratory Guide. Edited by Alan S. Gerstein Copyright © 2001 by Wiley-Liss, Inc. ISBNs: 0-471-37972-7 (Paper); 0-471-22390-5 (Electronic) 9 Restriction Endonucleases Derek Robinson, Paul R. Walsh, and Joseph A. Bonventre Background Information . 226 Which Restriction Enzymes Are Commercially Available? . 226 Why Are Some Enzymes More Expensive Than Others? . 227 What Can You Do to Reduce the Cost of Working with Restriction Enzymes? . 228 If You Could Select among Several Restriction Enzymes for Your Application, What Criteria Should You Consider to Make the Most Appropriate Choice? . 229 What Are the General Properties of Restriction Endonucleases? . 232 What Insight Is Provided by a Restriction Enzyme’s Quality Control Data? . 233 How Stable Are Restriction Enzymes? . 236 How Stable Are Diluted Restriction Enzymes? . 236 Simple Digests . 236 How Should You Set up a Simple Restriction Digest? . 236 Is It Wise to Modify the Suggested Reaction Conditions? . 237 Complex Restriction Digestions . 239 How Can a Substrate Affect the Restriction Digest? . 239 Should You Alter the Reaction Volume and DNA Concentration? . 241 Double Digests: Simultaneous or Sequential? . 242 225 Genomic Digests . 244 When Preparing Genomic DNA for Southern Blotting, How Can You Determine If Complete Digestion Has Been Obtained? . 244 What Are Your Options If You Must Create Additional Rare or Unique Restriction Sites? . 247 Troubleshooting . 255 What Can Cause a Simple Restriction Digest to Fail? . 255 The Volume of Enzyme in the Vial Appears Very Low. Did Leakage Occur during Shipment? . 259 The Enzyme Shipment Sat on the Shipping Dock for Two Days.
    [Show full text]
  • Phosphodiesterase 1B Knock-Out Mice Exhibit Exaggerated Locomotor Hyperactivity and DARPP-32 Phosphorylation in Response to Dopa
    The Journal of Neuroscience, June 15, 2002, 22(12):5188–5197 Phosphodiesterase 1B Knock-Out Mice Exhibit Exaggerated Locomotor Hyperactivity and DARPP-32 Phosphorylation in Response to Dopamine Agonists and Display Impaired Spatial Learning Tracy M. Reed,1,3 David R. Repaske,2* Gretchen L. Snyder,4 Paul Greengard,4 and Charles V. Vorhees1* Divisions of 1Developmental Biology and 2Endocrinology, Children’s Hospital Research Foundation, Cincinnati, Ohio 45229, 3Department of Biology, College of Mount St. Joseph, Cincinnati, Ohio 45233, and 4Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York 10021 Using homologous recombination, we generated mice lack- maze spatial-learning deficits. These results indicate that en- ing phosphodiesterase-mediated (PDE1B) cyclic nucleotide- hancement of cyclic nucleotide signaling by inactivation of hydrolyzing activity. PDE1B Ϫ/Ϫ mice showed exaggerated PDE1B-mediated cyclic nucleotide hydrolysis plays a signifi- hyperactivity after acute D-methamphetamine administra- cant role in dopaminergic function through the DARPP-32 and tion. Striatal slices from PDE1B Ϫ/Ϫ mice exhibited increased related transduction pathways. levels of phospho-Thr 34 DARPP-32 and phospho-Ser 845 Key words: phosphodiesterases; DARPP-32; dopamine- GluR1 after dopamine D1 receptor agonist or forskolin stimu- stimulated locomotor activity; spatial learning and memory; lation. PDE1B Ϫ/Ϫ and PDE1B ϩ/Ϫ mice demonstrated Morris Morris water maze; methamphetamine; SKF81297; forskolin Calcium/calmodulin-dependent phosphodiesterases (CaM- (CaMKII) and calcineurin and have the potential to activate PDEs) are members of one of 11 families of PDEs (Soderling et CaM-PDEs. Dopamine D1 or D2 receptor activation leads to al., 1999;Yuasa et al., 2001) and comprise the only family that acts adenylyl cyclase activation or inhibition, respectively (Traficante ϩ as a potential point of interaction between the Ca 2 and cyclic et al., 1976; Monsma et al., 1990; Cunningham and Kelley, 1993; nucleotide signaling pathways.
    [Show full text]
  • Disruption of the Aldolase a Tetramer Into Catalytically Active Monomers PETER T
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 5374-5379, May 1996 Biochemistry Disruption of the aldolase A tetramer into catalytically active monomers PETER T. BEERNINK* AND DEAN R. TOLANt Biology Department, Boston University, Boston, MA 02215 Communicated by Irwin A. Rose, Fox Chase Cancer Center, Philadelphia, PA, January 22, 1996 (received for review August 30, 1995) ABSTRACT The fructose-1,6-bisphosphate aldolase (EC interface loop of TIM resulted in a stable monomer with a 4.1.2.13) homotetramer has been destabilized by site-directed 103-fold reduction in kcat (11, 12). These studies have suggested mutagenesis at the two different subunit interfaces. A double that the quaternary structure is essential for proper catalytic mutant aldolase, Q125D/E224A, sediments as two distinct activity. species, characteristic of a slow equilibrium, with velocities Fructose-1,6-bisphosphate aldolase (Fru-1,6-P2; EC 4.1.2.13) is expected for the monomer and tetramer. The aldolase mono- an isologous homotetramer (Fig. 1A), each subunit ofwhich is an mer is shown to be catalytically active following isolation from eight-membered acq-barrel containing an active site near its sucrose density gradients. The isolated aldolase monomer had center (13). The two major subunit interfaces (A and B) are 72% of the specific activity of the wild-type enzyme and a distant (>20 A) from the Schiff base-forming Lys-229 (Fig. iB), slightly lower Michaelis constant, clearly indicating that the and aldolase does not exhibit cooperativity or allostery. Isolated quaternary structure is not required for catalysis. Cross- hybrids of isozymes indicated that subunits are catalytically linking of the isolated monomer confirmed that it does not independent; for example, A3B1 was indistinguishable from an rapidly reequilibrate with the tetramer following isolation.
    [Show full text]
  • Directions for Use Shrimp Alkaline Phosphatase, Recombinant (Rsap)
    Directions for Use Shrimp Alkaline Phosphatase, Recombinant (rSAP) Code Description Size 1B1633-1KU Shrimp Alkaline Phosphatase, Recombinant (rSAP) 1 vial, 1000 units (1 U/µL) 1B1633-5KU Shrimp Alkaline Phosphatase, Recombinant (rSAP) 5 vials, 1000 units each (1 U/µL) General Information Shrimp Alkaline Phosphatase, Recombinant (rSAP) is a heat-labile hydrolase enzyme produced in Pichia Pastoris that removes phosphate groups nonspecifically from 5’ ends of nucleic acid phosphomonoesters and proteins. This activity is most commonly utilized in molecular cloning to prevent self-ligation of linearized plasmid DNA and in 5’ end-labeling to facilitate the replacement of unlabeled phosphates with labeled phosphate groups. rSAP also prepares PCR products for DNA sequencing or SNP analysis, by dephosphorylating unincorporated dNTPs that would otherwise interfere with enzymatic reactions. VWR Life Science AMRESCO’s rSAP may be directly added to restriction enzyme digests and is conveniently inactivated 100% by heating at 65°C. This eliminates the need for vector purification, a step that is necessary when using alkaline phosphatases isolated from other sources, such as E. coli and calf intestine. rSAP works well in common buffers and does not require supplemental zinc or other additives. Removes 5’-phosphates from DNA, RNA, dNTPs and proteins Improves cloning efficiency by preventing vector recircularization 100% heat-inactivated at 65°C No vector purification necessary Removes unincorporated dNTPs in PCR products prior to DNA sequencing or SNP analysis Prepares templates for 5’-end labeling Dephosphorylates proteins Works in many different buffers without supplemental factors AMRESCO, LLC Corporate Headquarters, 28600 Fountain Parkway, Solon, OH 44139 Directions for Use Storage/Stability Stable at least 2 years when stored frozen (0 to -20°C).
    [Show full text]
  • Rapid Alkaline Phosphatase
    For life science research only. Not for use in diagnostic procedures. rAPid Alkaline Phosphatase Orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3.1.3.1 Cat. No. 04 898 133 001 1000 units Cat. No. 04 898 141 001 5000 units y Version 03 Content version : May 2019 Store at Ϫ15 to Ϫ25°C 1. What this Product Does Enzyme Characteristics Number of Tests Parameter Description 1 kit is designed for Source Recombinant alkaline phosphatase from bovine intes- • 1000 dephosphorylation reactions (Cat. No. 04 898 133 001) tine (1) expressed in Pichia pastoris • 5000 dephosphorylation reactions (Cat. No. 04 898 141 001) Molecular 56 kD (by SDS-PAGE, monomer) with a final reaction volume of 20 ␮l each. weight 2+ Pack Contents Subunits homodimer (Zn is essential for activity) Unit Definition One unit of rAPid Alkaline Phosphatase is the enzyme Label Contents / Function activity which hydrolyzes 1 ␮mol of 4-nitrophenyl rAPid Alkaline Phos- 0.5 M Tris/HCl, 1mM EDTA, pH 8.5 (20°C) phosphatase in 1 min at 37°C under assay conditions. phatase Buffer, Volume 1 U/␮l 10ϫ conc. Activity rAPid Alkaline Phos- • 1000 U (Cat. No. 04 898 133 001) Specific Approx. 1U/␮g according to (2) and (3). phatase • 5000 U (Cat. No. 04 898 141 001) Activity See data label for lot-specific values. Storage and Stability Specificity Alkaline Phosphatase catalyzes the hydrolysis of numerous phosphate esters, such as esters of primary Ϫ Ϫ If stored at 15 to 25°C the product is stable through the expiration and secondary alcohols, saccharides, cyclic alcohols, date printed on the label.
    [Show full text]
  • Clinical and Molecular Characterization of Patients with Fructose 1,6-Bisphosphatase Deficiency
    Article Clinical and Molecular Characterization of Patients with Fructose 1,6-Bisphosphatase Deficiency Niu Li 1,†, Guoying Chang 2,†, Yufei Xu 1, Yu Ding 2, Guoqiang Li 1, Tingting Yu 1, Yanrong Qing 1, Juan Li 2, Yiping Shen 1,3, Jian Wang 1,* and Xiumin Wang 2,* 1 Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China; [email protected] (N.L.); [email protected] (Y.X.); [email protected] (G.L.); [email protected] (T.Y.); [email protected] (Y.Q.); [email protected] (Y.S.) 2 Department of Endocrinology and Metabolism, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China; [email protected] (G.C.); [email protected] (Y.D.); [email protected] (J.L.) 3 Department of Laboratory Medicine, Boston Children’s Hospital, Boston, MA 02115, USA * Correspondence: [email protected] (J.W.); [email protected] (X.W.); Tel.: +86-21-3862-6161 (J.W. & X.W.); Fax: +86-21-5875-6923 (J.W. & X.W.) † These authors contributed equally to this work. Academic Editor: William Chi-shing Cho Received: 26 February 2017; Accepted: 17 April 2017; Published: 18 April 2017 Abstract: Fructose-1,6-bisphosphatase (FBPase) deficiency is a rare, autosomal recessive inherited disease caused by the mutation of the FBP1 gene, the incidence is estimated to be between 1/350,000 and 1/900,000. The symptoms of affected individuals are non-specific and are easily confused with other metabolic disorders.
    [Show full text]
  • Restriction Digest
    PROTOCOL 3: RESTRICTION DIGEST TEACHER VERSION THE GENOME TEACHING GENERATION PROTOCOL 3: RESTRICTION DIGEST PROTOCOL 3: RESTRICTION DIGEST TEACHER VERSION PRE-REQUISITES & GOALS STUDENT PRE-REQUISITES Prior to implementing this lab, students should understand: • The central dogma of how DNA bases code for mRNA and then for proteins • How DNA samples were collected and prepared for PCR • The steps that occur during the process of polymerase change reaction (PCR) • What restriction enzymes are and how they work • How the sequence variants in OXTR and CYP2C19 are affected by restriction enzyme digestion • The purpose of PROTOCOL 3 is to determine genotype STUDENT LEARNING GOALS 1. Perform restriction digestion of PCR products of CYP2C19 and/or OXTR. 2. Describe the possible genotypes for individuals with the CYP2C19 and/or OXTR genes. 3. Predict what each genotype will look like after gel electrophoresis and why. 2 TEACHING THE GENOME GENERATION | THE JACKSON LABORATORY PROTOCOL 3: RESTRICTION DIGEST TEACHER VERSION CURRICULUM INTEGRATION Use the planning notes space provided to reflect on how this protocol will be integrated into your classroom. You’ll find every course is different, and you may need to make changes in your preparation or set-up depending on which course you are teaching. Course name: 1. What prior knowledge do the students need? 2. How much time will this lesson take? 3. What materials do I need to prepare in advance? 4. Will the students work independently, in pairs, or in small groups? 5. What might be challenge points
    [Show full text]
  • Faqs for DNA End Modification: Dephosphorylation
    FAQs for DNA End Modification: Dephosphorylation 1. Does the DNA need to be purified after a restriction digest and prior to the dephosphorylation step? If the enzymes used in the restriction digest are heat inactivatable, then a purification step is not needed. If the enzymes used are not heat-inactivatable, then a clean-up step between the restriction digest and the dephosphorylation step is recommended. 2. Does the DNA need to be purified after the dephosphorylation step and prior to the ligation step? If you use rSAP or Antarctic Phosphatase, which are heat-inactivatable, then a clean- up step is not necessary. If the alkaline phosphatase used is CIP, which is not heat- inactivatable, then a clean-up step is necessary. 3. Which alkaline phosphatase, CIP, Antarctic or rSAP, works best? rSAP (NEB #M0371) is a superior choice because it combines the advantages of both CIP (NEB #M0290) and Antarctic Phosphatase (NEB #M0289). rSAP has a very high specific activity comparable to CIP, but CIP cannot be completely heat-inactivated. rSAP is heat-inactivated in 5 minutes, as is Antarctic Phosphatase, but rSAP is preferred over Antarctic Phosphatase because it does not require added zinc or any other co-factors. As a result, rSAP can be added directly to restriction enzyme digests. Additionally, after heat-inactivation of rSAP, it is not necessary to purify vector DNA prior to the ligation reaction. 4. Are the alkaline phosphatases active in NEBuffers? rSAP: rSAP is active in all restriction enzyme NEBuffers 1.1, 2.1, 3.1 and CutSmart™ Buffer, and can be added directly to digested DNA.
    [Show full text]
  • Expanded Roles of the Fanconi Anemia Pathway in Preserving Genomic Stability
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Expanded roles of the Fanconi anemia pathway in preserving genomic stability Younghoon Kee and Alan D. D’Andrea1 Department of Radiation Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA Studying rare human genetic diseases often leads to a gene products are believed to function in a common DNA better understanding of normal cellular functions. Fan- repair signaling pathway, the FA pathway, which closely coni anemia (FA), for example, has elucidated a novel cooperates with other DNA repair proteins for resolving DNA repair mechanism required for maintaining geno- DNA ICLs during replication (Fig. 1). A central event in mic stability and preventing cancer. The FA pathway, an the pathway is the monoubiquitination of FANCD2 and essential tumor-suppressive pathway, is required for pro- FANCI upon DNA damage, which is mediated by a group tecting the human genome from a specific type of DNA of upstream FA proteins (FANCA, FANCB, FANCC, damage; namely, DNA interstrand cross-links (ICLs). In FANCE, FANCF, FANCG, FANCL, and FANCM) that this review, we discuss the recent progress in the study are assembled into a large nuclear E3 ubiquitin ligase of the FA pathway, such as the identification of new complex, termed the ‘‘FA core complex’’ (Kennedy and FANCM-binding partners and the identification of D’Andrea 2005; Wang 2007). The monoubiquitinated RAD51C and FAN1 (Fanconi-associated nuclease 1) as FANCD2/FANCI heterodimer was shown to play multi- new FA pathway-related proteins.
    [Show full text]
  • Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects1
    Vol. 1, 103–120, December 2001 Molecular Cancer Therapeutics 103 Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects1 Wenhu Duan,2,3 Anupama Rangan,2 center of the external tetrad but within the loop region. Hariprasad Vankayalapati,2,3 Mu-Yong Kim,3 Molecular modeling using simulated annealing was 4 Qingping Zeng, Daekyu Sun, Haiyong Han, performed on the FQP-parallel G-quadruplex complex to 5 Oleg Yu. Fedoroff, David Nishioka, determine the optimum FQP orientation and key 6 Sun Young Rha, Elzbieta Izbicka, molecular interactions with the telomeric G-quadruplex Daniel D. Von Hoff, and Laurence H. Hurley3,7,8 structure. On the basis of the results of these studies, College of Pharmacy, The University of Texas, Austin, Texas 78712 two additional FQP analogues were synthesized, which [W. D., A. R., M-Y. K., Q. Z., O. Y. F., L. H. H.]; Institute for Drug Development, San Antonio, Texas 78245 [D. S., S. Y. R., E. I., were designed to test the importance of these key D. D. V. H.]; Department of Biology, Georgetown University, interactions. These analogues were evaluated in the Taq Washington, DC 20057 [D. N.]; and Arizona Cancer Center, Tucson, Arizona 85724 [H. H., D. D. V. H., L. H. H.] polymerase stop assay for G-quadruplex interaction. The data from this study and the biological evaluation of these three FQPs, using cytotoxicity and a sea urchin Abstract embryo system, were in accord with the predicted more In this study we have identified a new structural potent telomeric G-quadruplex interactions of the initial motif for a ligand with G-quadruplex interaction lead compound and one of the analogues.
    [Show full text]
  • 6.Start.Stop.07.Ppt [Read-Only]
    Accessory factors summary 1. DNA polymerase can’t replicate a genome. Solution ATP? No single stranded template Helicase + The ss template is unstable SSB (RPA (euks)) - No primer Primase (+) No 3’-->5’ polymerase Replication fork Too slow and distributive SSB and sliding clamp - Sliding clamp can’t get on Clamp loader (γ/RFC) + Lagging strand contains RNA Pol I 5’-->3’ exo, RNAseH - Lagging strand is nicked DNA ligase + Helicase introduces + supercoils Topoisomerase II + and products tangled 2. DNA replication is fast and processive DNA polymerase holoenzyme 1 Maturation of Okazaki fragments Topoisomerases control chromosome topology Catenanes/knots Topos Relaxed/disentangled •Major therapeutic target - chemotherapeutics/antibacterials •Type II topos transport one DNA through another 2 Starting and stopping summary 1. DNA replication is controlled at the initiation step. 2. DNA replication starts at specific sites in E. coli and yeast. 3. In E. coli, DnaA recognizes OriC and promotes loading of the DnaB helicase by DnaC (helicase loader) 4. DnaA and DnaC reactions are coupled to ATP hydrolysis. 5. Bacterial chromosomes are circular, and termination occurs opposite OriC. 6. In E. coli, the helicase inhibitor protein, tus, binds 7 ter DNA sites to trap the replisome at the end. 7. Eukaryotic chromosomes are linear, and the chromosome ends cannot be replicated by the replisome. 8. Telomerase extends the leading strand at the end. 9. Telomerase is a ribonucleoprotein (RNP) with RNA (template) and reverse-transcriptase subunits. Isolating DNA sequences that mediate initiation 3 Different origin sequences in different organisms E. Coli (bacteria) OriC Yeast ARS (Autonomously Replicating Sequences) Metazoans ???? Initiation in prokaryotes and eukaryotes Bacteria Eukaryotes ORC + other proteins load MCM hexameric helicases MCM (helicase) + RPA (ssbp) Primase + DNA pol α PCNA:pol δ + RFC MCM (helicase) + RPA (ssbp) PCNA:pol δ + RFC (clamp loader) Primase + DNA pol α PCNA:pol δ + DNA ligase 4 Crystal structure of DnaA:ATP revealed mechanism of origin assembly 1.
    [Show full text]